BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7886119)

  • 1. Synthesis and pharmacology of two new histamine receptor antagonists related to ranitidine.
    Navarro JJ; Almeida JF; Anaya J; Moran JR; Grande M; Caballero MC; Palacios B; Montero MJ; San Roman L
    Pharmazie; 1995 Jan; 50(1):12-5. PubMed ID: 7886119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between histaminergic and cholinergic pathways of gastric motility regulation.
    Milenov K; Todorov S; Vassileva M; Zamfirova R; Shahbazian A
    Methods Find Exp Clin Pharmacol; 1996; 18(1):33-9. PubMed ID: 8721254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential histamine H2-receptor antagonists. Synthesis, structure and activity of a few open models related to classical H2-antagonists.
    Sorba G; Fruttero R; Gasco A; Orsetti M
    Arzneimittelforschung; 1989 Sep; 39(9):1092-6. PubMed ID: 2574039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT; Daly MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of mifentidine, a novel H2-receptor antagonist.
    Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro actions of ranitidine, a new histamine H2-receptor antagonist.
    Daly MJ; Stables R
    Agents Actions; 1980 Apr; 10(1 Pt 2):190-1. PubMed ID: 6104417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
    Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
    Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential histamine H2-receptor antagonists: ranitidine analogues containing "semicarbazono equivalent" groups.
    Sorba G; Fruttero R; Calvino R; Gasco A; Orsetti M
    Arch Pharm (Weinheim); 1984 Jun; 317(6):496-501. PubMed ID: 6148051
    [No Abstract]   [Full Text] [Related]  

  • 12. Different effects of H1 and H2 blockers on the tone and the contractile activity of guinea pig stomach fundus.
    Milenov K; Todorov S; Vassileva M; Zamfirova R; Shahbazian A
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17(9):609-13. PubMed ID: 8786675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis and pharmacologic action of substituted imidazolyl- and thiazolylmethylthioethylguanidine].
    Buschauer A
    Arzneimittelforschung; 1987 Sep; 37(9):1003-7. PubMed ID: 2893625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of stobadine and histamine H1 and H2 blockers on histamine-induced contraction of guinea pig airways in vitro.
    Bilcíková L; Mátyás S; Bauer V
    Respiration; 1990; 57(2):104-8. PubMed ID: 1978385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
    Coruzzi G; Adami M; Pozzoli C; Poli E; Bertaccini G
    Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
    Nielsen ST
    J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autacoid blockaders. 1. Effects of histamine and of blockaders].
    Karashima T; Hara Y; Kamata M; Kuriyama H
    Nihon Rinsho; 1979; 37(7):2853-9. PubMed ID: 43408
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-activity studies of pyridinylalkyl-isocytosine H1-receptor antihistamines and identification of an active conformation.
    Cooper DG; Durant GJ; Ganellin CR; Ife RJ; Meeson ML; Sach GS
    Farmaco; 1991 Jan; 46(1):3-19. PubMed ID: 1675853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and combined H1-/H2 antagonist activity of mepyramine, pheniramine and cyclizine derivatives with cyanoguanidine, urea and nitroethenediamine partial structures].
    Schulze FR; Alisch RA; Buschauer A; Schunack W
    Arch Pharm (Weinheim); 1994 Jul; 327(7):455-62. PubMed ID: 7915515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of stobadine on respiratory and vascular smooth muscle in vivo: evidence for histamine receptor antagonist activity.
    Bauer V; Buran L; Babul'ová A
    Arch Int Pharmacodyn Ther; 1990; 304():232-46. PubMed ID: 1978643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.